-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-08-14
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is intended for resolving low-molecular-weight proteins and peptides that may be poorly separated by conventional Tris-SDS-PAGE. It supports research workflows including denaturing and non-denaturing electrophoresis, but it is not intended for diagnostic, clinical, or medical use.
-
Sodium Nitroprusside in Vascular Assays
2026-08-14
Use Sodium Nitroprusside as a controlled nitric oxide donor challenge to separate vascular smooth muscle responsiveness from upstream hypertension mechanisms. This practical guide connects sex-stratified angiotensin II research with tissue, platelet, and integrated assay workflows, including preparation parameters and troubleshooting strategies.
-
Tamoxifen and PINK1: Designing Better Cancer Assays
2026-08-13
Tamoxifen is more than a selective estrogen receptor modulator: in conditional genetics, it can shape the biological readouts researchers measure. This article explains how to use Tamoxifen CreER-mediated gene knockout models to interrogate PINK1, mitochondrial iron, autophagy, and tumorigenesis without confusing induction effects with disease biology.
-
FAK Inhibitor 14: Applied Research Workflows
2026-08-13
FAK Inhibitor 14 enables pharmacological interrogation of FAK/Src signaling in migration, EMT, and cholesterol-adapted ovarian cancer models. This guide combines practical dosing, pathway-level readouts, comparative assay design, and troubleshooting for reproducible cancer biology research.
-
Radicicol Workflows for Hsp90 and Metabolic Research
2026-08-12
Radicicol is a versatile Hsp90 inhibitor for connecting protein-quality control with adipogenesis, apoptosis, inflammation, and antigen cross-presentation assays. This guide converts its pharmacology into practical dose-finding, control design, nanoparticle studies, and troubleshooting workflows.
-
Z-LEHD-FMK: From Apoptosis to Translation
2026-08-12
A thought-leadership guide to using Z-LEHD-FMK as an irreversible caspase-9 inhibitor for causal pathway dissection, time-resolved apoptosis assays, cancer research, and neuroprotection in spinal cord injury. The article connects mitochondrial apoptosis biology with translational study design, emphasizing orthogonal readouts, model-specific controls, and the limits of extrapolating cytoprotection into therapeutic claims.
-
Ginsenoside Rg1 as a Gut–Brain Assay Probe
2026-08-11
Ginsenoside Rg1 is a Panax-derived triterpene saponin that offers more than a neuroprotective phenotype: it can serve as a mechanistic probe of gut–immune–brain communication. This article explains how to design, control, and interpret Rg1 experiments using causal immune validation rather than single-endpoint outcome measures.
-
Atorvastatin: From Mevalonate Flux to Ferroptosis
2026-08-11
Atorvastatin is an HMG-CoA reductase inhibitor with applications extending from cholesterol metabolism research to ferroptosis-oriented hepatocellular carcinoma studies. This guide explains how to connect pathway perturbation, cell-state biology, and assay design without overinterpreting model-specific results.
-
Z-WEHD-FMK: Mapping Caspase-1 to Pyroptosis
2026-08-10
A translational perspective on how Z-WEHD-FMK and Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK can help researchers connect inflammatory caspase activity with pyroptosis, Golgi remodeling, infection biology, and cancer mechanism.
-
Ethacridine Lactate Monohydrate in Cell Assays
2026-08-09
Learn how to use Ethacridine lactate monohydrate as a research-use antiseptic agent for microbial control without confusing contamination management with a biological mechanism. The workflow connects disciplined sterility testing with YAP-TEAD and super-enhancer assays, emphasizing vehicle controls, cell-compatibility pilots, and fresh solution handling.
-
Multiomics Maps Acute Liver Injury Drug Responses
2026-08-08
The reference study combines co-expression modules, regulatory analysis, transcriptomics, and proteomics to compare bifendate with muaddil sapra in CCl4-induced acute liver injury. Its main contribution is a systems-level map showing partly shared but mechanistically distinct treatment responses, while also identifying candidate transcriptional, noncoding-RNA, and protein regulators for future validation.
-
Laminin (925-933): An Assay Design Framework
2026-08-07
Laminin (925-933) is a defined Laminin B1 chain peptide for separating receptor-mediated adhesion from chemotaxis and downstream phenotype. This article develops an evidence-based workflow that connects peptide assay design with lessons from human brain-slice and tau pathology research.
-
Antipyrine in CNS Research: Protocols, BBB Models, and Tips
2026-08-07
Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) is the gold-standard tool for high-throughput blood-brain barrier (BBB) and pharmacokinetic studies, offering unmatched solubility and reproducibility. This article delivers workflow-driven guidance—spanning protocol design, troubleshooting, and the latest BBB model innovations—to accelerate CNS drug discovery and pain research.
-
HSP90-Dependent Nanoparticles Boost CD8+ Immunity in FMD Vac
2026-08-06
This study introduces HACC-TNF-α-VLP nanoparticles as a novel delivery system that harnesses Hsp90-dependent antigen cross-presentation to enhance CD8+ T cell and mucosal immunity against foot-and-mouth disease (FMD). The findings highlight a promising strategy for next-generation FMD vaccines that improve cellular and mucosal immune responses.
-
Pomalidomide (CC-4047): Mechanistic Insights for Hematologic
2026-08-06
Unlock the advanced mechanism and assay guidance for Pomalidomide (CC-4047) in hematological malignancy research. This article delivers deep analysis and practical protocols, highlighting unique molecular insights beyond standard workflows.